Oxytocic Pharmaceuticals Market is projected to grow up to USD 1.8 billion by 2027 growing at a CAGR of 6% during the forecasting period 2021-2027.

The medication oxytocin, which is produced from the peptide of the same name and sold under the brand name Pitocin, is routinely used on women during labour to stimulate contractions. This can not only speed up labour and cut down on delivery time, but it can help stop bleeding after delivery. It is almost always given to patients as an injection into a vein or muscle. The medicine, however, is not without negative effects, the most dangerous of which is excessive uterine contractions after overconsumption, which could jeopardise the health of the baby. Other adverse effects include nausea and a slowed heart rate. Oxytocin has also been linked to allergic reactions, such as anaphylaxis. The medicine is still deemed to be extremely safe to use and is included in the WHO's List of Essential Medicines. Oxytocin can also be used as a medicine to help the mother become ready to nurse. The medicine has the ability to increase the production of breast milk, which is important for moms who are unable to do so naturally.
View Complete Report: https://whipsmartmi.com/report/oxytocic-pharmaceuticals-market
The Oxytocic Pharmaceuticals Market report has been categorized as below
By Treatment type
Pre-eclampsia/Eclampsia
Postpartum Hemorrhage
Others
By End use type
Hospitals
Maternity Centre
Clinics
By Region
North America
Europe
Asia Pacific
Rest of World
Request a Sample of this Report: @ https://whipsmartmi.com/sample/ph0799/Oxytocic-Pharmaceuticals-Market
Explore other reports from”Pharmaceuticals “sector @
https://whipsmartmi.com/Category/Pharmaceuticals
Contact Us:
Neeraj
WhipSmart Market Intelligence
7264 Magistrate Terrace,
Mississauga,
Ontario L5W 1H8
Canada
[email protected]